The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of predictive biomarkers for nivolumab in metastatic clear cell renal cell carcinoma (mccRCC) using RECIST and immune-related (IR) RECIST.
 
Jean-Christophe Pignon
No Relationships to Disclose
 
Opeyemi Jegede
No Relationships to Disclose
 
Christine Horak
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Megan Wind-Rotolo
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Other Relationship - Huntsworth Health (I)
 
Paul J. Catalano
Consulting or Advisory Role - Lilly
 
Jonian Grosha
No Relationships to Disclose
 
Abdallah Flaifel
No Relationships to Disclose
 
Jesse Novak
No Relationships to Disclose
 
Kathleen Margaret Mahoney
No Relationships to Disclose
 
Gordon J. Freeman
Consulting or Advisory Role - Bethyl Laboratories; Bristol-Myers Squibb; Lilly; Novartis; Novartis (I); Quiet Therapeutics; Roche/Genentech; Seagen; Surface Oncology (I); Xios Therapeutics
Research Funding - Novartis (I); Roche/Genentech (I)
Patents, Royalties, Other Intellectual Property - Amplimmune/Astrazeneca; Boehringer Ingelheim; Bristol-Myers Squibb/Medarex; EMD Serono; Merck; Novartis; Novartis (I); Pfizer (I); Roche/Genentech; Roche/Genentech (I)
 
Arlene Sharpe
Honoraria - MI biotech (I); MPM Capital (I)
Consulting or Advisory Role - Adaptimmune; Bethyl Laboratories; Quiet therapeutics; Seagen; SQZ Biotech; Surface Oncology; Xios Therapeutics
Research Funding - Ipsen; Novartis; Roche/Genentech; VCB
Patents, Royalties, Other Intellectual Property - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Dako/Agilent Technologies; Merck; Merck Serono; Novartis; Roche
Travel, Accommodations, Expenses - Adaptimmune
 
Catherine J. Wu
Stock and Other Ownership Interests - Neon Therapeutics; Neon Therapeutics (I)
Consulting or Advisory Role - Neon Therapeutics; Neon Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Neon Therapeutics, Advisory Board Member; Neon Therapeutics, Advisory Board Member (I)
 
F. Stephen Hodi
Employment - Dana-Farber Cancer Institute
Consulting or Advisory Role - Amgen; EMD Serono; Genentech/Roche; Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy; patent pending royalties received on MICA related disorders application to institution per institutional IP policy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - alligent; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; Eisai; Exelixis; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Peloton Therapeutics; Pfizer; Prometheus; Roche/Genentech
Research Funding - Agensys (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - advisory boards/consultancy
 
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Acceleron Pharma; Agenus; Alexion Pharmaceuticals; Argos Therapeutics; Array BioPharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celldex; Eisai; Exelixis; Genentech; Genoptix; Glactone Pharma; Idera; Merck; Nektar; Novartis; Peleton; Pfizer; X4 Pharma
 
David F. McDermott
Consulting or Advisory Role - Alexion Pharmaceuticals; Array BioPharma; Bristol-Myers Squibb; Eisai; exelixis; Genentech/Roche; Merck; Novartis; Pfizer; X4 Pharma
Research Funding - Prometheus (Inst)
 
Sabina Signoretti
Consulting or Advisory Role - AACR; AstraZeneca/MedImmune; Merck; NCI
Research Funding - AstraZeneca (Inst); Exelixis (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for CDX2 antibody from Biogenex Laboratories, Inc.